Introducing a gatekeeping system for amyloid status assessment in mild cognitive impairment.
Background: In patients with mild cognitive impairment (MCI), enhanced cerebral amyloid-β plaque burden is a high-risk factor to develop dementia with Alzheimer's disease (AD). Not all patients have immediate access to the assessment of amyloid status (A-status) via gold standard methods. It may the...
| Publicado en: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 49; no. 13; pp. 4478 - 4490 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Nov2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |